دورية أكاديمية
P-199 Baseline neutrophil to lymphocyte ratio predicts survival in patients with metastatic colorectal cancer treated with cetuximab plus avelumab (CAVE) as a rechallenge strategy
| العنوان: | P-199 Baseline neutrophil to lymphocyte ratio predicts survival in patients with metastatic colorectal cancer treated with cetuximab plus avelumab (CAVE) as a rechallenge strategy |
|---|---|
| المؤلفون: | Ciardiello, D., Famiglietti, V., Napolitano, S., Terminiello, M., Borrelli, C., Vitiello, P., Pietrantonio, F., Avallone, A., Normanno, N., Maiello, E., Latiano, T., Cremolini, C., Santabarbara, G., Pinto, C., Santini, D., Esposito, L., Di Liello, A., Troiani, T., Ciardiello, F., Martinelli, E., Martini, G. |
| المصدر: | Annals of Oncology ; volume 32, page S167-S168 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2021 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2021.05.254 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2021.05.254Test https://api.elsevier.com/content/article/PII:S0923753421014435?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753421014435?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.C0670E2F |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2021.05.254 |
|---|